Blood gas analysers and monitors

Immediate bedside results increase sales

In 2006 blood gas analysers and monitors earned manufacturers revenues of around US$360.5 million, and revenues could reach US$470 million in 2013, according to a new market report from Frost & Sullivan (F&S).

Siemens Medical Solutions RapidPoint® 400 Series
Siemens Medical Solutions RapidPoint® 400 Series

‘Laboratory tests that used to take around 30 minutes for the result to be obtained are now a thing of the past; currently manufactured point of care devices yield immediate answers,’ the report’s author, research analyst C R Hema Varshika, explained. That instant bedside capability, along with a rising patient population is, she believes, the cause of a notable sales boost. 


The main challenges for manufacturers include each country having its own purchasing system, which will only change when countries adopt uniform laws. The author attributes other problems to the high levels of brand consciousness among hospitals and ‘intense competition from local participants’. This, Ms Farshika suggests, can be overcome through innovative products and effective marketing strategies. ‘Proactive marketing of technologically advanced and user-friendly products will lead to a rise in market share,’ she then predicts.


F&S points out that this analysis - ‘The European Blood Gas Analysers and Monitors Market’ (M00B – 56) - is part of its Patient Monitoring Subscription, which includes research on: Remote Patient Monitoring and the Strategic Analysis of the European Neurological Monitoring Market.

For a virtual brochure, e-mail Radhika Menon Theodore - Corporate Communications at rmtheodore@frost.com, giving your name, company name, title, phone number, e-address, city, state, and country.

(http://www.patientmonitoring.frost.com)

08.03.2007

More on the subject:

Related articles

Photo

News • MRD assessment

Liquid biopsy to detect breast cancer relapse up to 5 years in advance

Newly developed technology can detect breast cancer relapses up to five years in advance. This advance could represent a turning point in post-treatment follow-up, the researchers hope.

Photo

News • AI-assisted platelet imaging

Monitoring blood clotting in real-time

Researchers have found a way to observe clotting activity in blood as it happens — without needing invasive procedures. This could open the door to better treatment of coronary artery disease (CAD).

Photo

Prof. Dr. Agnes Kant

‘Side effects are not a side issue’

Discovering knowledge about side effects needs to be faster and better. In her oration, Prof. Dr. Agnes Kant, Professor by special appointment of Innovation of Pharmacovigilance, calls for more…

Related products

Subscribe to Newsletter